Global Information
회사소개 | 문의 | 비교리스트

무바늘 주사기 : 의료기기 파이프라인 평가

Needle Free Injections - Medical Devices Pipeline Assessment, 2019

리서치사 GlobalData
발행일 2019년 05월 상품 코드 357852
페이지 정보 영문 161 Pages
가격
US $ 2,500 ₩ 2,971,000 PDF (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,942,000 PDF (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,913,000 PDF (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


무바늘 주사기 : 의료기기 파이프라인 평가 Needle Free Injections - Medical Devices Pipeline Assessment, 2019
발행일 : 2019년 05월 페이지 정보 : 영문 161 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

무바늘 주사기 관련 파이프라인 제품에 대해 조사했으며, 개발 단계별 동향 및 제품의 주요 개발 기업, 현재 지속중인 임상시험, 업계의 최근 동향 등의 정보를 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 무바늘 주사기의 개요

제3장 개발중인 제품

  • 무바늘 주사기 - 파이프라인 제품 : 개발 단계별
  • 무바늘 주사기 - 파이프라인 제품 : 지역(국가)별
  • 무바늘 주사기 - 파이프라인 제품 : 규제 경로별
  • 무바늘 주사기 - 파이프라인 제품 : 승인 시기별(추정)

제4장 무바늘 주사기 - 개발중인 파이프라인 제품 : 기업별

  • 무바늘 주사기 기업 - 파이프라인 제품 : 개발 단계별
  • 무바늘 주사기 - 파이프라인 제품 : 개발 단계별

제5장 무바늘 주사기 개발 기업과 제품의 개요

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Crossject SA
  • Enable Injections, LLC
  • Eternity Healthcare Inc.
  • EuroJet Medical Kft.
  • Glide Pharmaceutical Technologies Limited
  • Inovio Pharmaceuticals Inc
  • Medical International Technologies (Mit Canada) Inc.
  • PharmaJet, Inc.
  • Teva Pharmaceutical Industries Limited

제6장 무바늘 주사기 - 최근 동향

제7장 부록

KSA 17.07.31

List of Tables

  • Table 1: Needle Free Injections - Pipeline Products by Stage of Development
  • Table 2: Needle Free Injections - Pipeline Products by Territory
  • Table 3: Needle Free Injections - Pipeline Products by Regulatory Path
  • Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
  • Table 5: Needle Free Injections - Ongoing Clinical Trials
  • Table 6: Needle Free Injections Companies - Pipeline Products by Stage of Development
  • Table 7: Needle Free Injections - Pipeline Products by Stage of Development
  • Table 8: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Needle-Free System - Product Status
  • Table 10: Needle-Free System - Product Description
  • Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: JetTouch System - Overactive Bladder - Product Status
  • Table 13: JetTouch System - Overactive Bladder - Product Description
  • Table 14: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Zeneo ID Human Needle-Free Injection Device - Product Status
  • Table 16: Zeneo ID Human Needle-Free Injection Device - Product Description
  • Table 17: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status
  • Table 18: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description
  • Table 19: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
  • Table 20: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
  • Table 21: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
  • Table 22: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
  • Table 23: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
  • Table 24: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
  • Table 25: Enable Injections Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Enable Smart enFuse - Product Status
  • Table 27: Enable Smart enFuse - Product Description
  • Table 28: Enable Injections Inc - Ongoing Clinical Trials Overview
  • Table 29: Enable Smart enFuse - Comparison of Two Infusion Devices with Respect to Pharmacokinetics, Safety and Tolerability of Hizentra: Investigational Wearable Infusor and the Crono S-pid-50 Infusion Pump
  • Table 30: Enesi Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: ImplaVax Device - Product Status
  • Table 32: ImplaVax Device - Product Description
  • Table 33: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Multi Channel Needle-Free Injection Device - Product Status
  • Table 35: Multi Channel Needle-Free Injection Device - Product Description
  • Table 36: Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Intradermal Pen Injector - Product Status
  • Table 38: Intradermal Pen Injector - Product Description
  • Table 39: Intradermal Syringe - Product Status
  • Table 40: Intradermal Syringe - Product Description
  • Table 41: Mega Jet - Product Status
  • Table 42: Mega Jet - Product Description
  • Table 43: Multi-Port Orifices - Product Status
  • Table 44: Multi-Port Orifices - Product Description
  • Table 45: Needle-Free Vaccine Delivery Device - Product Status
  • Table 46: Needle-Free Vaccine Delivery Device - Product Description
  • Table 47: Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: MED-JET MBX Injector - Product Status
  • Table 49: MED-JET MBX Injector - Product Description
  • Table 50: MIT-H-III - Product Status
  • Table 51: MIT-H-III - Product Description
  • Table 52: MIT-H-IV-1 - Product Status
  • Table 53: MIT-H-IV-1 - Product Description
  • Table 54: MIT-H-IV-5 - Product Status
  • Table 55: MIT-H-IV-5 - Product Description
  • Table 56: MIT-H-VI Dental Injector - Product Status
  • Table 57: MIT-H-VI Dental Injector - Product Description
  • Table 58: PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Pre-filled Syringe - Product Status
  • Table 60: Pre-filled Syringe - Product Description
  • Table 61: Tropis - Product Status
  • Table 62: Tropis - Product Description

List of Figures

  • Figure 1: Needle Free Injections - Pipeline Products by Stage of Development
  • Figure 2: Needle Free Injections - Pipeline Products by Territory
  • Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path
  • Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
  • Figure 5: Needle Free Injections - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Needle Free Injections - Medical Devices Pipeline Assessment, 2019" provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Needle Free Injections under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Needle Free Injections under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Needle Free Injections Overview

3 Products under Development

  • 3.1 Needle Free Injections - Pipeline Products by Stage of Development
  • 3.2 Needle Free Injections - Pipeline Products by Territory
  • 3.3 Needle Free Injections - Pipeline Products by Regulatory Path
  • 3.4 Needle Free Injections - Pipeline Products by Estimated Approval Date
  • 3.5 Needle Free Injections - Ongoing Clinical Trials

4 Needle Free Injections - Pipeline Products under Development by Companies

  • 4.1 Needle Free Injections Companies - Pipeline Products by Stage of Development
  • 4.2 Needle Free Injections - Pipeline Products by Stage of Development

5 Needle Free Injections Companies and Product Overview

  • 5.1 B. Braun Melsungen AG Company Overview
  • 5.2 Boston Scientific Corp Company Overview
  • 5.3 Crossject SA Company Overview
  • 5.4 Enable Injections Inc Company Overview
  • 5.5 Enesi Pharma Ltd Company Overview
  • 5.6 Eternity Healthcare Inc. Company Overview
  • 5.7 Inovio Pharmaceuticals Inc Company Overview
  • 5.8 Medical International Technologies (Mit Canada) Inc Company Overview
  • 5.9 PharmaJet Inc Company Overview
  • 5.10 Queen's University Company Overview
  • 5.11 Takeda Pharmaceutical Co Ltd Company Overview
  • 5.12 Teva Pharmaceutical Industries Ltd Company Overview

6 Needle Free Injections- Recent Developments

  • 6.1 May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
  • 6.2 May 02, 2019: Teva reports first quarter 2019 financial results
  • 6.3 Apr 30, 2019: Merck announces first-quarter 2019 financial results
  • 6.4 Apr 25, 2019: Baxter reports first-quarter 2019 results
  • 6.5 Apr 24, 2019: Boston Scientific announces results for first quarter 2019
  • 6.6 Apr 10, 2019: Enesi Pharma's ImplaVax platform shortlisted for Best New Vaccine Technology/Platform at the Vaccine Industry Excellence (ViE) Awards 2019
  • 6.7 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
  • 6.8 Mar 29, 2019: Daiichi Sankyo announces chief executive officer (CEO) change
  • 6.9 Mar 05, 2019: Valeritas announces fourth quarter and full year 2018 financial results
  • 6.10 Mar 04, 2019: Antares Pharma announces board changes

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top
전화 문의
F A Q